Ensemble machine learning prediction and variable importance analysis of 5-year mortality after cardiac valve and

José Castela Forte1,2,3, Hubert E Mungroop4, Fred de Geus4

  • 1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands. j.n.alves.castela.cardoso.forte@umcg.nl.

Scientific Reports
|February 11, 2021
PubMed

Insights

Machine learning accurately predicts 5-year mortality after cardiac surgery using routine data. Post-operative urea emerged as a novel predictor, alongside age and creatinine, improving risk assessment for patients undergoing valve or bypass operations.

Area of Science:

  • Cardiovascular Surgery
  • Medical Informatics
  • Machine Learning in Healthcare

Background:

  • Cardiac valve operations have higher mortality than coronary artery bypass grafting (CABG).
  • Predictors for long-term mortality after cardiac surgery are not well-established.
  • Accurate prediction models are crucial for patient management and risk stratification.

Purpose of the Study:

  • To develop and validate an ensemble machine learning model for predicting 5-year mortality after cardiac operations.
  • To identify novel peri-operative predictors of long-term mortality.
  • To compare the predictive performance across different cardiac surgical procedures.

Main Methods:

  • Utilized an ensemble machine learning algorithm (Super Learner).
  • Trained the model on prospectively collected peri-operative data from 8241 patients.
  • Included 88 routinely collected peri-operative variables for analysis.

Main Results:

  • Ensemble machine learning demonstrated high predictive accuracy for 5-year mortality (e.g., mitral valve: 0.846, aortic valve: 0.838).
  • Post-operative urea was identified as a novel and significant predictor of mortality.
  • The model effectively integrated known risk factors like age and postoperative creatinine with new predictors.

Conclusions:

  • Ensemble machine learning accurately predicts long-term mortality using routine peri-operative data in cardiac surgery.
  • Post-operative urea is a significant, previously unrecognized predictor of mortality after cardiac operations.
  • This approach enhances risk stratification and can inform clinical decision-making for cardiac surgery patients.

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
162
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
121
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
171
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
109
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
128
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
125